• Explore /
  • Poster
  • / Phase 1/2a study of PRL-02, a long-acting intramuscular (IM) depot injection of abiraterone decanoate, in patients (pts) with advanced prostate cancer.

Phase 1/2a study of PRL-02, a long-acting intramuscular (IM) depot injection of abiraterone decanoate, in patients (pts) with advanced prostate cancer.

Abstract Video & Slides Poster

Authors

null

Neal D. Shore

Carolina Urologic Research Center, Myrtle Beach, SC

Neal D. Shore , Jose W. Avitia , James L. Bailen , Luke T. Nordquist , William Richardson , Cody J. Peer , William Douglas Figg , Jacqueline M. Walling , Joel Robert Eisner , Matthew Sharp , Robert J. Schotzinger , William R. Moore , Ronald F. Tutrone

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2023 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Genitourinary Cancer—Prostate, Testicular, and Penile

Track

Genitourinary Cancer—Prostate, Testicular, and Penile

Sub Track

Prostate Cancer– Advanced/Hormone-Sensitive

Clinical Trial Registration Number

NCT04729114

Citation

J Clin Oncol 41, 2023 (suppl 16; abstr TPS5117)

DOI

10.1200/JCO.2023.41.16_suppl.TPS5117

Abstract #

TPS5117

Poster Bd #

201b

Abstract Disclosures

Similar Posters

First Author: Jose W. Avitia

First Author: Tim Warneke

First Author: Mohammad O. Atiq

First Author: Pedro C. Barata